MRV
MRV
Discontinued
DIN Number
02216981
Drug Class
Human
Market Date
Nov 11, 1996
Company
HC
hollister-stier laboratories llc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02216981
AIG Number0628573001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AX OTHER BACTERIAL VACCINES
Product Specifications
Dosage FormSuspension
Route of AdministrationIntradermal
,
Subcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (6)
HEMOPHILUS INFLUENZAEActive
Strength: 150 M / ML
Monograph: HEMOPHILUS INFLUENZAE
KLEBSIELLA PNEUMONIAEActive
Strength: 150 M / ML
Monograph: KLEBSIELLA PNEUMONIAE
NEISSERIA CATARRHALISActive
Strength: 150 M / ML
Monograph: NEISSERIA CATARRHALIS
STAPHYLOCOCCUS AUREUSActive
Strength: 1200 M / ML
Monograph: STAPHYLOCOCCUS AUREUS
STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAEActive
Strength: 150 M / ML
Monograph: STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE
STREPTOCOCCUS (VIRIDANS AND NON-HEMOLYTIC)Active
Strength: 200 M / ML
Monograph: STREPTOCOCCUS (VIRIDANS AND NON-HEMOLYTIC)